← Back to headlines





Personalized mRNA cancer vaccine shows promising results in melanoma study
A personalized mRNA cancer vaccine has demonstrated promising results in a phase 3 study, showing effectiveness in preventing the recurrence or spread of melanoma after surgery.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories

Croatia and Serbia Ramp Up Mosquito Control Amid West Nile Outbreak
26m ago

Doja Cat Opens Up About Past Struggles With Alcohol and Cocaine
36m ago
Finland Adjusts African Swine Fever Containment Measures Amid Outbreak Response
47m ago

Novartis Halts Autoimmune Cell Therapy Trials After Patient Deaths
2h ago